Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Association Between Duration of Breastfeeding and Maternal Hypertension: A Systematic Review and Meta-Analysis / Guangbo Qu in Breastfeeding Medicine, Vol. 13, n°5 (Juin 2018)
Titre : Association Between Duration of Breastfeeding and Maternal Hypertension: A Systematic Review and Meta-Analysis Type de document : texte imprimé Auteurs : Guangbo Qu, Auteur ; Lingling Wang, Auteur ; Xue Tang, Auteur Année de publication : 2018 Article en page(s) : pp.318-326 Langues : Anglais (eng) Catégories : Allaitement long
Durée de l'allaitement
Résumé : Objectives: Recently, an increasing number of studies have implied that breastfeeding has a protective effect on maternal hypertension, but it remains controversial. The aim of this study is to evaluate the effect of breastfeeding on maternal hypertension through meta-analysis.
Materials and Methods: Eligible studies were searched and identified in various databases. Meta-analysis was conducted to assess the association between the duration of breastfeeding and maternal hypertension.
Results: Seven eligible studies that contained 444,759 participants were included in our study. Meta-analysis of these seven studies showed a significant protective effect of breastfeeding on maternal hypertension. Specifically, pooled odds ratios (ORs) of hypertension for >0–6, >6–12, and >12 months of breastfeeding were 0.92 (95% confidence interval [CI]: 0.88–0.96, I2 = 67.5%), 0.89 (95% CI: 0.86–0.92, I2 = 0), and 0.88 (95% CI: 0.84–0.93, I2 = 43.9%), respectively, compared with nonbreastfeeding mothers, and the pooled OR of hypertension was 0.93 (95% CI: 0.91–0.95, I2 = 40.8%) for women who breastfed compared with women who had not. Furthermore, the pooled hazard ratio of hypertension was 1.34 (95% CI: 1.17–1.52, I2 = 58.7%) for women who did not breastfeed compared with women who breastfed for more than 12 months for their first child.
Conclusion: Different durations of breastfeeding have different protective effects against the development of maternal hypertension, and breastfeeding for >12 months has a better effect than <12 months.
in Breastfeeding Medicine > Vol. 13, n°5 (Juin 2018) . - pp.318-326[article]Effect of Lactation on Maternal Hypertension: A Systematic Review / Eliana Bonifacino in Breastfeeding Medicine, Vol 13., n°9 (Novembre 2018)
Titre : Effect of Lactation on Maternal Hypertension: A Systematic Review Type de document : texte imprimé Auteurs : Eliana Bonifacino, Auteur ; Eleanor B. Schwartz, Auteur ; Hyejo Jun, Auteur Année de publication : 2018 Article en page(s) : pp.578-588 Langues : Anglais (eng) Catégories : Hypertension artérielle
Maladie de la mère
Revue de la littérature
Résumé : Introduction: Hypertension is relatively common in pregnancy, and pregnancy may unmask hypertension among women who are predisposed to it. Lactation may be a means through which to mitigate pregnancy-related vascular risk. The impact of lactation on maternal blood pressure, and the duration of any effect, remains unclear. This study aimed at systematically reviewing the literature evaluating the impact of lactation on the development of hypertension.
Materials and Methods: We searched PubMed, including EMBASE and MEDLINE, for studies that reported on the association between breastfeeding and maternal risk of hypertension that were published in a peer-reviewed source. The quality of the studies included was assessed by using the Newcastle-Ottawa Scale.
Results: Nineteen studies met all inclusion criteria for this review. Of the four studies with short-term follow-up, 50% showed a protective association. The fifteen studies with longer-term follow-up were stratified by outcome assessed. Sixty-seven percent of the studies that evaluated for elevated blood pressure and 100% of the studies evaluating for an outcome of hypertension showed a protective association. The minimum duration of lactation associated with a benefit was 1 month. This association was demonstrated in follow-up periods as long as two to three decades. Studies that showed a protective association had overall higher quality ratings.
Discussion: Lactation is associated with a beneficial effect on maternal blood pressure that persists for decades. These results add to the growing body of literature demonstrating the protective association of lactation on maternal cardiovascular risk. Providers may incorporate the decreased risk of hypertension into their counseling on the maternal benefits of lactation.
in Breastfeeding Medicine > Vol 13., n°9 (Novembre 2018) . - pp.578-588[article]Estimation of Atenolol Transfer Into Milk and Infant Exposure During Its Use in Lactating Women / Ei Mon Phyo Lwin in Journal of Human Lactation, Vol. 34, n°3 (Août 2018)
Titre : Estimation of Atenolol Transfer Into Milk and Infant Exposure During Its Use in Lactating Women Type de document : texte imprimé Auteurs : Ei Mon Phyo Lwin, Auteur ; Cobus Gerber, Auteur ; Catherine Leggett, Auteur Année de publication : 2018 Article en page(s) : pp. 592-599 Langues : Anglais (eng) Catégories : Composition du lait
Consultant en lactation
Thérapeutique médicamenteuse de la mère
Résumé : "Abstract
Atenolol lactation information is limited, and controversy exists over the safety of its use during breastfeeding. In this study, important parameters including milk-to-plasma ratio, ratio of infant plasma to maternal plasma, infant daily dosage, and relative infant dose were investigated. The findings from this study add information to existing data about atenolol transfer in human milk. This may help guide health professionals in decision making regarding the safety of beta blockers used by mothers during breastfeeding.
The aims of the study were to quantify concentrations of atenolol in human plasma and milk, to evaluate atenolol pharmacokinetics in lactating women, and to investigate subsequent infant exposure to atenolol via mother’s milk.
In this prospective, longitudinal observational study, participants were lactating mothers (N = 3), 1 to 4 months postpartum, who had been taking atenolol for therapeutic reasons, and one 4-month-old breastfed infant. Eight milk samples were collected over 24 hr at different time points, together with a single blood sample from each lactating mother and the infant, and quantified using a new sensitive liquid chromatography mass spectrometry method developed for this study.
Peak milk concentrations of atenolol were observed in the women at 4 hr (Tmax) after oral administration. The dose-normalized maximum concentrations (Cmax) of all patients were similar. The mean milk-to-plasma ratio of the patients who were taking 25 to 100 mg of atenolol was 8.57%. In the mother–infant pair study, the ratio (%) of infant plasma drug concentration to maternal plasma drug concentration observed (18.87%) was similar to the relative infant dose estimated (18.20%). The relative infant dose values (13.96%-18.20%) for all patients were within 10% to 25% of maternal dosage.
Atenolol use during breastfeeding should be undertaken with some precaution. If clinically indicated, an alternate beta blocker may be preferred."
[Résumé de l'auteur]
in Journal of Human Lactation > Vol. 34, n°3 (Août 2018) . - pp. 592-599[article]Treating Hypertension During Breastfeeding / Philip O. Anderson in Breastfeeding Medicine, Vol. 13, n°2 (Mars 2018)
Titre : Treating Hypertension During Breastfeeding Type de document : texte imprimé Auteurs : Philip O. Anderson, Auteur Année de publication : 2018 Article en page(s) : pp. 95-96 Langues : Anglais (eng) Catégories : Cardiologie
Résumé : "More nursing mothers might be receiving antihypertensive drugs under the new, stricter hypertension guidelines. The information on antihypertensive drugs during lactation is quite variable, with some drugs well established as acceptable and others with no human lactation information at all. This column reviews the various options for treating hypertension. Further study details and references can be found in the corresponding drug records in LactMed.®"
[Extrait de l'article]
En ligne : https://www.liebertpub.com/doi/full/10.1089/bfm.2017.0236 Permalink :
in Breastfeeding Medicine > Vol. 13, n°2 (Mars 2018) . - pp. 95-96[article]Vol. 13, n°5 - Juin 2018 (Bulletin de Breastfeeding Medicine)
[n° ou bulletin]
Titre : Vol. 13, n°5 - Juin 2018 Type de document : texte imprimé Année de publication : 2018 Langues : Anglais (eng) Catégories : Analgésique
Durée de l'allaitement
Expression du lait
Frein à l'allaitement
Grand prématuré (avant 34 semaines)
IHAB Initiative Hôpital Ami des Bébés
Professionnel de santé
Retour à domicile
Note de contenu : Editorial
- The Impact of Vitamin D on the Maternal and Infant Epigenome: The Role of Pregnancy and Breastfeeding
- ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production, Second Revision 2018
- Alcohol Use During Breastfeeding
- Association Between Duration of Breastfeeding and Maternal Hypertension: A Systematic Review and Meta-Analysis
-The Analgesic Effects of Maternal Milk Odor on Newborns: A Meta-Analysis
- Analyzing Factors That Impact Breastfeeding Duration in the Postpartum Period: A Secondary Analysis of PRAMS Data
- Barriers to Breastfeeding in Female Physicians
- Determinants of Successful Direct Breastfeeding at Hospital Discharge in High-Risk Premature Infants
- Human Milk Biomarkers of Secretory Activation in Breast Pump-Dependent Mothers of Premature Infants
- Effect of Herbal Compresses for Maternal Breast Engorgement at Postpartum: A Randomized Controlled
- Outcomes of Video-Assisted Teaching for Latching in Postpartum Women: A Randomized Controlled
- Effects of Maternal Vitamin D Supplementation on the Maternal and Infant EpigenomeTrialTrial
Public Health and Policy
- Trends in Maternity Care Practice Skin-to-Skin Contact Indicators: United States, 2007–2015
- Serratia marcescens Colonization Causing Pink Breast Milk and Pink Diapers: A Case Report and Literature Review
Permalink : [n° ou bulletin]Contient
- ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production, Second Revision 2018 / Wendy Brodribb in Breastfeeding Medicine, Vol. 13, n°5 (Juin 2018)
- Association Between Duration of Breastfeeding and Maternal Hypertension: A Systematic Review and Meta-Analysis / Guangbo Qu in Breastfeeding Medicine, Vol. 13, n°5 (Juin 2018)
- The Analgesic Effects of Maternal Milk Odor on Newborns: A Meta-Analysis / Shiyi Zhang in Breastfeeding Medicine, Vol. 13, n°5 (Juin 2018)
- Barriers to Breastfeeding in Female Physicians / Rebecca M. Cantu in Breastfeeding Medicine, Vol. 13, n°5 (Juin 2018)
RéservationRéserver ce document
Code-barres Cote Support Localisation Section Disponibilité 00014 PE Revue IPA Revues Sorti jusqu'au 22/02/2019Vol 13., n°9 - Novembre 2018 (Bulletin de Breastfeeding Medicine)
PermalinkVol. 34, n°3 - Août 2018 - Special Issue: Social Justice and Lactation (Bulletin de Journal of Human Lactation)